CAS: 138071-82-6 - Gadobutrol

Formula: C₁₈H₃₁GaN₄O₉

InChI: InChI=1/C18H34N4O9.Gd/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+3/p-3/t14-,15-;/s2

InChI key: InChIKey=ZPDFIIGFYAHNSK-ZCTZICQLNA-K

SMILES: O=C1[O-][Gd+3]234567[O-]C(=O)C[N]87CC[N]6(C1)CC[N]5(CC(=O)[O-]2)CC[N]4(CC8)C(CO)C([OH]3)CO

Sinonimi:

• (10-((1RS,2SR)-2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium
• (SA-8-1425362′5′)-[rel-10-[(2R,3S)-2-(Hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN¹,κN⁴,κN⁷,κN¹⁰,κO¹,κO⁴,κO⁷]gadolinium
• Gadobutrol [INN]
• Gadograf
• Gadolinium, (10-(2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7)-
• Gadolinium, [10-[2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN¹,κN⁴,κN⁷,κN¹⁰,κO¹,κO⁴,κO⁷]-, [SA-8-1425362′5′-(R*,S*)]-
• Gadolinium, [rel-10-[(2R,3S)-2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN¹,κN⁴,κN⁷,κN¹⁰,κO¹,κO⁴,κO⁷]-, (SA-8-1425362′5′)-
• Gadovist
• Protovist
• Zk 135079
• gallium 2,2',2''-{10-[(2R,3S)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl}triacetate

Gadobutrol

CAS: 138071-82-6

• Formula: C₁₈H₃₁GdN₄O₉
• Peso molecolare: 604.72

Gallium 10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate

CAS: 138071-82-6

• Purezza: 98%
• Peso molecolare: 475.10699462890625

Gadavist

CAS: 138071-82-6

Gadavist is a gadolinium-based contrast agent that is used in radiology to visualize the brain …

• Formula: C₁₈H₃₁GaN₄O₉
• Purezza: Min. 95%
• Peso molecolare: 517.2 g/mol

Gadolinium,[10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-

CAS: 138071-82-6

• Formula: C₁₈H₃₁GaN₄O₉
• Purezza: 99%
• Peso molecolare: 517.1831